» Articles » PMID: 7647801

Expression Analysis of the Ataxin-1 Protein in Tissues from Normal and Spinocerebellar Ataxia Type 1 Individuals

Overview
Journal Nat Genet
Specialty Genetics
Date 1995 May 1
PMID 7647801
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused by expansion of a CAG trinucleotide repeat which codes for glutamine in the protein ataxin-1. We have investigated the effect of this expansion on ataxin-1 by immunoblot analysis. The wild-type protein is detected in both normal and affected individuals; however, a mutant protein which varies in its migration properties according to the size of the CAG repeat is detected in cultured cells and tissues from SCA1 individuals. The protein has a nuclear localization in all normal and SCA1 brain regions examined but a cytoplasmic localization of ataxin-1 was also observed in cerebellar Purkinje cells. Our data show that in SCA1, the expanded alleles are faithfully translated into proteins of apparently normal stability and distribution.

Citing Articles

Investigation of Spinocerebellar Ataxia (SCA) Disease in Iranian Patients and Accurate Trinucleotide Repeat Detection in the SCA3 by TP-PCR Method.

Sharafi S, Rezvani Z Mol Neurobiol. 2024; 62(3):2756-2763.

PMID: 39155322 DOI: 10.1007/s12035-024-04434-8.


Mapping SCA1 regional vulnerabilities reveals neural and skeletal muscle contributions to disease.

Duvick L, Southern W, Benzow K, Burch Z, Handler H, Mitchell J JCI Insight. 2024; 9(9.

PMID: 38512434 PMC: 11141930. DOI: 10.1172/jci.insight.176057.


Longitudinal single-cell transcriptional dynamics throughout neurodegeneration in SCA1.

Tejwani L, Ravindra N, Lee C, Cheng Y, Nguyen B, Luttik K Neuron. 2023; 112(3):362-383.e15.

PMID: 38016472 PMC: 10922326. DOI: 10.1016/j.neuron.2023.10.039.


Altered calcium signaling in Bergmann glia contributes to spinocerebellar ataxia type-1 in a mouse model of SCA1.

Nanclares C, Noriega-Prieto J, Labrada-Moncada F, Cvetanovic M, Araque A, Kofuji P Neurobiol Dis. 2023; 187:106318.

PMID: 37802154 PMC: 10624966. DOI: 10.1016/j.nbd.2023.106318.


Therapeutic Strategies for Spinocerebellar Ataxia Type 1.

Kerkhof L, van de Warrenburg B, van Roon-Mom W, Buijsen R Biomolecules. 2023; 13(5).

PMID: 37238658 PMC: 10216181. DOI: 10.3390/biom13050788.